文献速递腹部MR

深度学习辅助在肝脏增强MRI上鉴别经病理证实的非典型与典型肝细胞癌及非肝细胞癌病变

Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.
PubMed 文献 · Eur Radiol · 2021-01-06

该回顾性研究纳入118例患者共150个经病理证实的肝脏病变(93个肝细胞癌,57个非肝细胞癌),训练3D卷积神经网络在增强MRI上鉴别肝细胞癌与非肝细胞癌,包括47%具有非典型影像特征(不符合LI-RADS LR5标准)的肝细胞癌。模型总体准确率87.3%,AUC为0.912,且病变越不典型准确率越低。

要点

  • 卷积神经网络在增强MRI上鉴别肝细胞癌与非肝细胞癌的总体准确率为87.3%,AUC为0.912。
  • 肝细胞癌与非肝细胞癌的敏感度/特异度分别为92.7%/82.0%和82.0%/92.7%。
  • 47%的肝细胞癌病变具有非典型影像特征,不符合LI-RADS LR5标准。

关键影像表现/征象

  • 47%的肝细胞癌病变显示非典型影像特征,不符合LI-RADS LR5标准。
  • 卷积神经网络性能与病变分级系统相关,病变显示的非典型影像特征越多,模型准确率越低。

诊断标准与关键数值

  • 卷积神经网络总体准确率87.3%。
  • 肝细胞癌检测敏感度92.7%,特异度82.0%。
  • 非肝细胞癌检测敏感度82.0%,特异度92.7%。
  • 受试者工作特征曲线下面积0.912。
  • 计算时间<3 ms。

临床应用与阅片要点

  • 作者认为,经非典型表现、病理证实且不符合LI-RADS LR5标准的肝细胞癌病变训练的卷积神经网络能正确鉴别肝细胞癌与其他肝脏恶性肿瘤,可能扩展影像学诊断在具有非典型特征的原发性肝癌中的作用。
  • 作者指出,该卷积神经网络总体准确率87.3%、计算时间<3 ms,为作为决策支持工具用于临床应用铺平了道路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To train a deep learning model to differentiate between pathologically proven hepatocellular carcinoma (HCC) and non-HCC lesions including lesions with atypical imaging features on MRI.

METHODS: This IRB-approved retrospective study included 118 patients with 150 lesions (93 (62%) HCC and 57 (38%) non-HCC) pathologically confirmed through biopsies (n = 72), resections (n = 29), liver transplants (n = 46), and autopsies (n = 3). Forty-seven percent of HCC lesions showed atypical imaging features (not meeting Liver Imaging Reporting and Data System [LI-RADS] criteria for definitive HCC/LR5). A 3D convolutional neural network (CNN) was trained on 140 lesions and tested for its ability to classify the 10 remaining lesions (5 HCC/5 non-HCC). Performance of the model was averaged over 150 runs with random sub-sampling to provide class-balanced test sets. A lesion grading system was developed to demonstrate the similarity between atypical HCC and non-HCC lesions prone to misclassification by the CNN.

RESULTS: The CNN demonstrated an overall accuracy of 87.3%. Sensitivities/specificities for HCC and non-HCC lesions were 92.7%/82.0% and 82.0%/92.7%, respectively. The area under the receiver operating curve was 0.912. CNN's performance was correlated with the lesion grading system, becoming less accurate the more atypical imaging features the lesions showed.

CONCLUSION: This study provides proof-of-concept for CNN-based classification of both typical- and atypical-appearing HCC lesions on multi-phasic MRI, utilizing pathologically confirmed lesions as "ground truth."

KEY POINTS: • A CNN trained on atypical appearing pathologically proven HCC lesions not meeting LI-RADS criteria for definitive HCC (LR5) can correctly differentiate HCC lesions from other liver malignancies, potentially expanding the role of image-based diagnosis in primary liver cancer with atypical features. • The trained CNN demonstrated an overall accuracy of 87.3% and a computational time of < 3 ms which paves the way for clinical application as a decision support instrument.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Oestmann PM, Wang CJ, Savic LJ, et al. Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver. Eur Radiol. 2021. PMID: 33409782. doi:10.1007/s00330-020-07559-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。